These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 20819676)

  • 1. Gefitinib attenuates murine pulmonary fibrosis induced by bleomycin.
    Wang P; Tian Q; Liang ZX; Yang Z; Xu SF; Sun JP; Chen LA
    Chin Med J (Engl); 2010 Aug; 123(16):2259-64. PubMed ID: 20819676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gefitinib prevents bleomycin-induced lung fibrosis in mice.
    Ishii Y; Fujimoto S; Fukuda T
    Am J Respir Crit Care Med; 2006 Sep; 174(5):550-6. PubMed ID: 16741154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal growth factor receptor tyrosine kinase inhibition augments a murine model of pulmonary fibrosis.
    Suzuki H; Aoshiba K; Yokohori N; Nagai A
    Cancer Res; 2003 Aug; 63(16):5054-9. PubMed ID: 12941834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VEGFR-2 antagonist SU5416 attenuates bleomycin-induced pulmonary fibrosis in mice.
    Ou XM; Li WC; Liu DS; Li YP; Wen FQ; Feng YL; Zhang SF; Huang XY; Wang T; Wang K; Wang X; Chen L
    Int Immunopharmacol; 2009 Jan; 9(1):70-9. PubMed ID: 18976720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin attenuates gefitinib-induced exacerbation of pulmonary fibrosis by inhibition of TGF-β signaling pathway.
    Li L; Huang W; Li K; Zhang K; Lin C; Han R; Lu C; Wang Y; Chen H; Sun F; He Y
    Oncotarget; 2015 Dec; 6(41):43605-19. PubMed ID: 26497205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Gefitinib inhibits α-smooth muscle actin expression in mice with bleomycin-induced lung fibrosis].
    Li L; Li WF; Cai L; Yuan WF; Huang WJ
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Dec; 30(12):2675-8. PubMed ID: 21177177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antifibrotic effects of focal adhesion kinase inhibitor in bleomycin-induced pulmonary fibrosis in mice.
    Kinoshita K; Aono Y; Azuma M; Kishi J; Takezaki A; Kishi M; Makino H; Okazaki H; Uehara H; Izumi K; Sone S; Nishioka Y
    Am J Respir Cell Mol Biol; 2013 Oct; 49(4):536-43. PubMed ID: 23642017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of andrographolide on the concentration of cytokines in BALF and the expressions of type I and III collagen mRNA in lung tissue in bleomycin-induced rat pulmonary fibrosis].
    Zhu HL; Huang CL; Wang WJ; Zhan XQ; Fan XM
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jul; 27(7):725-9. PubMed ID: 21722520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antifibrotic action of pirfenidone and prednisolone: different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis.
    Oku H; Shimizu T; Kawabata T; Nagira M; Hikita I; Ueyama A; Matsushima S; Torii M; Arimura A
    Eur J Pharmacol; 2008 Aug; 590(1-3):400-8. PubMed ID: 18598692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gefitinib Inhibits Bleomycin-Induced Pulmonary Fibrosis via Alleviating the Oxidative Damage in Mice.
    Li L; Cai L; Zheng L; Hu Y; Yuan W; Guo Z; Li W
    Oxid Med Cell Longev; 2018; 2018():8249693. PubMed ID: 29849916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor activity of the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor gefitinib (ZD1839, Iressa) in non-small cell lung cancer cell lines correlates with gene copy number and EGFR mutations but not EGFR protein levels.
    Helfrich BA; Raben D; Varella-Garcia M; Gustafson D; Chan DC; Bemis L; Coldren C; Barón A; Zeng C; Franklin WA; Hirsch FR; Gazdar A; Minna J; Bunn PA
    Clin Cancer Res; 2006 Dec; 12(23):7117-25. PubMed ID: 17145836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imatinib as a novel antifibrotic agent in bleomycin-induced pulmonary fibrosis in mice.
    Aono Y; Nishioka Y; Inayama M; Ugai M; Kishi J; Uehara H; Izumi K; Sone S
    Am J Respir Crit Care Med; 2005 Jun; 171(11):1279-85. PubMed ID: 15735062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of activin receptor-like kinase 5 attenuates bleomycin-induced pulmonary fibrosis.
    Higashiyama H; Yoshimoto D; Kaise T; Matsubara S; Fujiwara M; Kikkawa H; Asano S; Kinoshita M
    Exp Mol Pathol; 2007 Aug; 83(1):39-46. PubMed ID: 17274978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined epidermal growth factor receptor targeting with the tyrosine kinase inhibitor gefitinib (ZD1839) and the monoclonal antibody cetuximab (IMC-C225): superiority over single-agent receptor targeting.
    Matar P; Rojo F; Cassia R; Moreno-Bueno G; Di Cosimo S; Tabernero J; Guzmán M; Rodriguez S; Arribas J; Palacios J; Baselga J
    Clin Cancer Res; 2004 Oct; 10(19):6487-501. PubMed ID: 15475436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of interleukin-17 on murine pulmonary fibroblast proliferation, transformation and collagen synthesis].
    Dong Z; Kang Q; Lei W; Zhong H; Tai W; Wang D
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Jan; 32(1):75-9. PubMed ID: 22366009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of pravastatin on bleomycin-induced acute lung injury and pulmonary fibrosis.
    Kim JW; Rhee CK; Kim TJ; Kim YH; Lee SH; Yoon HK; Kim SC; Lee SY; Kwon SS; Kim KH; Kim YK
    Clin Exp Pharmacol Physiol; 2010 Nov; 37(11):1055-63. PubMed ID: 20659133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of plasminogen activator inhibitor-1 by RNA interference attenuates pulmonary fibrosis.
    Senoo T; Hattori N; Tanimoto T; Furonaka M; Ishikawa N; Fujitaka K; Haruta Y; Murai H; Yokoyama A; Kohno N
    Thorax; 2010 Apr; 65(4):334-40. PubMed ID: 20388759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the therapeutic potential of the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib in preclinical models of bladder cancer.
    Dominguez-Escrig JL; Kelly JD; Neal DE; King SM; Davies BR
    Clin Cancer Res; 2004 Jul; 10(14):4874-84. PubMed ID: 15269164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance of fibrogenic responses to glucocorticoid and 2-methoxyestradiol in bleomycin-induced lung fibrosis in mice.
    Langenbach SY; Wheaton BJ; Fernandes DJ; Jones C; Sutherland TE; Wraith BC; Harris T; Schuliga MJ; McLean C; Stewart AG
    Can J Physiol Pharmacol; 2007 Jul; 85(7):727-38. PubMed ID: 17823636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of expression of heat shock protein 70 by gefitinib and its contribution to pulmonary fibrosis.
    Namba T; Tanaka K; Hoshino T; Azuma A; Mizushima T
    PLoS One; 2011; 6(11):e27296. PubMed ID: 22096546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.